Business
AeroDel signs exclusive licensing arrangement with Zydus for launching Aerolife Mini™, India's First Foldable, 'Always Attached' pMDI Enhancer
AeroDel Technology Innovations Pvt. Ltd., a Mumbai-based respiratory medical device company, announces an exclusive licensing arrangement with Zydus Lifesciences Limited for the commercial pan-India launch of its A202 device in March 2026. Developed and manufactured by AeroDel, A202 is being made available to patients as Aerolife Mini™.
About this update from Zydus Lifesciences Limited
[{"type":"list","items":[{"val":[{"type":"text","content":"A202, a design-led innovation, is launched in an exclusive marketing arrangement with Zydus Lifesciences Limited","length":112,"tagName":"p"}]},{"val":[{"type":"text","content":"The launch marks India's first foldable next-gen pMDI (pressurised Metered Dose Inhaler) enhancer, available as Aerolife Mini™","length":130,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":242,"olType":false},{"type":"text","content":"MUMBAI, India, March 19, 2026 /PRNewswire/ -- AeroDel Technology Innovations Pvt. Ltd., a Mumbai-based respiratory medical device company, announces an exclusive licensing arrangement with Zydus Lifesciences Limited for the commercial pan-India launch of its A202 device in March 2026. Developed and manufactured by AeroDel, A202 is being made available to patients as Aerolife Mini™.","length":384,"tagName":"p"},{"type":"image","alt":"AeroDel's pressurised metered-dose inhaler (pMDI) Enhancer, marketed in India under the Aerolife Mini brand.","displaySize":"","headline":null,"caption":"AeroDel's pressurised metered-dose inhaler (pMDI) Enhancer, marketed in India under the Aerolife Mini brand.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/8186d900b10bd5db24a327a5b672cd3e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/IARbNdfozswzgVRcEfVP8A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNQ--/https://media.zenfs.com/en/prnewswire.com/8186d900b10bd5db24a327a5b672cd3e","width":400,"height":400}},"href":"https://mma.prnewswire.com/media/2937945/AeroDel_A202_device.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"India faces a significant and growing burden of chronic respiratory diseases such as asthma, COPD, and bronchiectasis. Millions of patients rely on long-term inhaled therapy to control symptoms, reduce exacerbations, and maintain quality of life. Inhaler technique is frequently suboptimal, with nearly 94% of patients making at least one critical error while using inhaler devices, resulting in drug loss and reduced therapeutic benefit.","length":438,"tagName":"p"},{"type":"text","content":"Spacer devices are known to enhance lung deposition of pMDI-delivered drugs by reducing coordination errors. However, this segment remains largely undifferentiated — most exist...